Aspect Imaging News
14 articles
growth-positive
Embrace® Neonatal MRI System by Aspect Imaging - Groundbreaking MRI INSIDE the NICU!
Aspect Imaging has developed the Embrace Neonatal MRI System, a new approach to MRI in the NICU. The system is designed to be placed inside the NICU, reducing the time and risks associated with transporting infants to an external MRI facility. It enables safer imaging of infants and provides easier access for medical staff. The system is acoustically quieter, requires no cooling system, and has low power consumption. It does not require a special safety zone or RF-shielded room. The operating and maintenance costs are much lower than conventional superconductor MRIs. Aspect Imaging aims to assist neonatologists with clinical diagnoses and improve neonatal care.
CustomersPartners
growth-positive
BWH Press Release - Brigham and Women's Hospital
Brigham and Womens Hospital in Boston has installed a new MRI system specifically designed for safe imaging of newborns in the Neonatal Intensive Care Unit (NICU). The system, called EMBRACE, is the first FDA-approved, NICU-dedicated MRI system in the U.S. It will enhance the hospitals research capabilities and expand neurocritical care for newborns. The MRI system is quieter and uses lower power consumption compared to traditional scanners. It will be used initially for applied medical research. The system was manufactured by Aspect Imaging and was hoisted into the NICU via crane.
Expand
Aspect Imaging and Brightonix Imaging Will Be Showcasing the SimPET Simultaneous Preclinical PET/MRI Insert at WMIC 2018
Aspect Imaging announces that Professor Moshe Gomori, Head of MRI and Neuroradiology Unit, Hadassah Medical Center, Jerusalem, Israel, has joined the company Advisory Board
growth-positive
Revolutionary MRI device images preemies right in the NICU
Israeli company Aspect Imaging has developed Embrace, the worlds first MRI machine specifically designed for neonatal intensive care units (NICUs). The Embrace system allows for MRI scans of premature babies without the need to transport them to a separate MRI room, providing diagnostic-quality images directly in the NICU. The system is silent, safe, and emits a low-level external magnetic field. Aspect Imaging has received FDA approval for the Embrace system in the United States and has signed distribution agreements in Europe and North America. The company is also in negotiations for deals in China. Aspect Imaging has invested over $150 million in developing its MRI technology and is now working on a bedside MRI system for emergency rooms.
Customers
growth-positive
Aspect Imaging Receives CE Mark for Embrace Neonatal MRI System in the NICU
Aspect Imaging has received CE marking for its neonatal-dedicated MRI system, Embrace Neonatal MRI System. The system allows for the preparation and scanning of newborns without having to transport them from the neonatal intensive care unit (NICU). It reduces the time and risks involved with transportation to external facilities. The Embrace Neonatal MRI System is placed inside the NICU and enables safer imaging of infants. It can prep and scan in less than an hour and is acoustically quieter compared to traditional whole-body scanners. The system does not require a special safety zone or an RF-shielded room. The operating and maintenance costs are lower than conventional superconductor MRIs. Aspect Imaging designs and develops compact MRI and NMR systems for various markets.
Customers
growth-positive
Aspect Imaging To Present Its Embrace® Neonatal MRI System at RSNA 2017
Aspect Imaging, a developer of compact high-performance MRI systems, is set to present the benefits of its Embrace Neonatal MRI System at RSNA 2017 in Chicago. The system enables the preparation and scanning of newborns in less than an hour, without having to transport them from the Neonatal Intensive Care Unit (NICU). Aspect Imaging is also collaborating with Natus Medical Inc, a leading provider of healthcare products and services, to exclusively distribute the Embrace Neonatal MRI system in North America.
PartnersExpand
Aspect Imaging Receives CE Mark for Embrace® Neonatal MRI System in the NICU
growth-positive
MRI Inside NICU: Interview with Uri Rapoport, CEO of Aspect Imaging
Israeli company Aspect Imaging has received FDA clearance for its Embrace Neonatal MRI, a device that can be placed inside the neonatal intensive care unit (NICU) to provide brain imaging for newborns. The Embrace system addresses the challenges of moving fragile neonates to a separate MRI room by allowing the scans to be performed within the NICU. The system also enables medical devices to be in close proximity to the scanner, eliminating the need for replacement or removal. Aspect Imaging plans to extend the functionality of the Embrace system to image other parts of the body. The company expects its technology to make MRI scans more accessible and convenient, potentially opening up new markets in the medical industry. Aspect Imaging is also working on a dedicated stroke MRI system and new products for the inline process industry.
Customers
growth-positive
UPDATE: Aspect Imaging wins FDA 510(k) for Embrace neonatal MRI
Aspect Imagings Embrace Neonatal MRI system has received FDA 510(k) clearance. The system is designed specifically for neonatal brain and head imaging, and it can be used on neonates with a head circumference of up to 38 cm and a weight between 1 and 4.5 kg. The Embrace system includes a temperature-controlled incubator that can be placed directly into the MRI system to reduce movement. The system allows for urgent access to the neonates if necessary, with the baby typically able to be removed from the system in less than 30 seconds. Aspect Imaging raised $30 million in April to support the development of the Embrace Neonatal MRI system and a newer, stroke-dedicated MRI system.
Investment
Aspect Imaging Announces FDA Clearance of EmbraceTM;the First Dedicated Neonatal MRI System for the NICU
growth-positive
Israeli MRI co Aspect Imaging raises $30m
Israeli compact MRI systems developer Aspect Imaging has raised $30 million in a financing round to complete the development of its Embrace Neonatal MRI system and Stroke-dedicated MRI System. The companys self-shielded permanent magnet MRI technology platform allows for the placement of systems at the Point-of-Care, making them more accessible to patients. Aspect Imaging has previously launched its WristView MRI system and has developed eight products using the same technology platform. The funding will enable the company to continue developing game-changing products based on its cutting-edge technology.
Investment
growth-positive
Israeli compact MRI co Aspect Imaging raises $20m
Israeli high-performance MRI developer Aspect Imaging has raised $20 million in its latest round of funding. The company has developed compact and affordable MRI machines that make diagnostic tests more accessible to patients worldwide. The funding brings the total amount raised by the company to $120 million. Aspect Imaging has already developed and released a family of eight different MRI products, specializing in the medical, advanced industrial, and preclinical fields. The companys innovative medical solutions include the compact Embrace Neonatal MRI System and the FDA-approved WristView MRI System. The funding will help the company expand its reach and make MRI scans more available to patients and researchers around the world.
Investment
growth-positive
Aspect Imaging Announces FDA Clearance of M2™ Compact MRI System for Clinical Imaging of the Wrist
Aspect Imaging, a developer of compact high-performance magnets, has received clearance from the U.S. Food and Drug Administration (FDA) for its M2 compact MRI system for diagnostic imaging of the wrist. The system is designed for rapid imaging of the wrist, offering affordability, compact design, patient-centric ergonomics, powerful MR-based imaging, and simple, quiet operation. The company plans to begin commercialization of the instrument in the summer of 2013 and run clinical studies at multiple sites including the University of California in Los Angeles (UCLA).
CustomersExpand